Identification and validation of basic fibroblast growth factor as a prognostic biomarker for the response of lung adenocarcinoma patients to bevacizumab treatment
- Resource Type
- Article
- Source
- In
Immunobiology November 2023 228(6) - Subject
- Language
- ISSN
- 0171-2985